ICARS Strategy 2022-2026
Since its inception in spring 2019, ICARS has bolted out of the starting blocks and achieved a great deal in its first years. These achievements were based on the strong strategic pillars that were developed in the early days to address the clear need, expressed by low- and middle-income countries, for tailored solutions to support National Action Plan implementation.
In this, our first official strategy, we draw on the lessons we have learnt, and project ourselves into the future. Guided by our vision of a world without drug-resistant infections, we have revised our outcome framework and refined the scope and goals of each of our interconnected pillars. In the following we are pleased to present a succinct overview of ICARS unique value proposition, followed by our overarching strategy that will run until 2026, as well as a roadmap that details our planned activities per pillar.
We look forward to what the next four years hold and anticipate many fruitful partnerships and initiatives to deliver on our mission, working with low- and middle-income countries to tackle antimicrobial resistance.
Resource type: Report
Date: 30. July 2023
Sector: One Health
Share this project on socials